TRRI (TRRI) Stock Price & Analysis
TRRI (TRRI) rose 0.00% to USD 0 as of June 10, 2026 at 13:32 UTC, according to Nexqual real-time market data.
TRRI last closed at USD 0; the session ranged USD 0–0 on volume of 3,683 shares. Market capitalization is $1,806, with a 52-week range of USD 0–0.07 (PNK). Source: Nexqual, June 10, 2026 at 13:32 UTC.
Key Statistics (as of June 10, 2026 at 13:32 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.07 |
| Volume | 3,683 shares |
| Market Cap | $1,806 |
| Exchange | PNK |
Technical Analysis (TRRI)
Nexqual's technical model rates TRRI "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 13:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Analyst Ratings (TRRI)
Wall Street analysts rate TRRI "None", per Nexqual as of June 10, 2026 at 13:32 UTC.
| Consensus Rating | None |
|---|
Earnings (TRRI)
Source: Nexqual, June 10, 2026 at 13:32 UTC.
Financials & Fundamentals (TRRI)
| Total Revenue | $4.73M |
|---|---|
| Revenue Growth (YoY) | +23.60% |
| Gross Margin | +9.09% |
| Operating Margin | -6.72% |
| Profit Margin | +0.68% |
| ROE | +2.85% |
| Debt / Equity | 76.4 |
| Current Ratio | 1.43 |
| Total Cash | $63,501 |
| Total Debt | $690,703 |
| Free Cash Flow | $198,143 |
Source: Nexqual, June 10, 2026 at 13:32 UTC.
Financial Health Score (TRRI)
Nexqual rates TRRI's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 13:32 UTC.
| Growth | Strong — Revenue +24% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $64K cash, no debt |
| Cash Flow | Mixed — FCF $198K, slim 4.2% margin |
| Efficiency | Weak — ROE 3%, ROA -1.6% |
Ownership (TRRI)
| Shares Outstanding | 1.51M |
|---|
Source: Nexqual, June 10, 2026 at 13:32 UTC.
Leadership (TRRI)
TRRI is led by Robert W. Rosner (age 60), Chief Executive Officer, President and Director, per Nexqual as of June 10, 2026 at 13:32 UTC.
| Chief Executive Officer, President and Director | Robert W. Rosner (age 60) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UVSS | UNIVERSAL SYSTEM INC WASHINGTON | USD 0 | ▲ 0% |
| XCPL | XCPCNL Business Services Corpor | USD 0 | ▲ 0% |
| EMGE | Emergent Health Corp. | USD 0 | ▲ 0% |
| KONEF | WELLBEING DIGITAL SCIENCES INC | USD 0 | ▲ 0% |
| ROVMF | ROVER CRITICAL MINERALS CORP. | USD 0.09 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:32 UTC. This page is informational and not investment advice.